Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

Dirk De Ruysscher*, Rinus Wanders, Lizza E. Hendriks, Angela van Baardwijk, Bart Reymen, Ruud Houben, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Anne-Marie C. Dingemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1958-1961
Number of pages4
JournalJournal of Thoracic Oncology
Volume13
Issue number12
DOIs
Publication statusPublished - Dec 2018

Keywords

  • Non-small cell lung cancer
  • oligometastases
  • long-term survival
  • phase II trial
  • CELL LUNG-CANCER

Cite this